These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34067361)

  • 1. Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay.
    Brinc D; Biondi MJ; Li D; Sun H; Capraru C; Smookler D; Zahoor MA; Casey J; Kulasingam V; Feld JJ
    Viruses; 2021 May; 13(6):. PubMed ID: 34067361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens.
    Moat SJ; Zelek WM; Carne E; Ponsford MJ; Bramhall K; Jones S; El-Shanawany T; Wise MP; Thomas A; George C; Fegan C; Steven R; Webb R; Weeks I; Morgan BP; Jolles S
    Ann Clin Biochem; 2021 Mar; 58(2):123-131. PubMed ID: 33269949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.
    Meyers E; Heytens S; Formukong A; Vercruysse H; De Sutter A; Geens T; Hofkens K; Janssens H; Nys E; Padalko E; Deschepper E; Cools P
    Microbiol Spectr; 2021 Oct; 9(2):e0017821. PubMed ID: 34549995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples.
    Morley GL; Taylor S; Jossi S; Perez-Toledo M; Faustini SE; Marcial-Juarez E; Shields AM; Goodall M; Allen JD; Watanabe Y; Newby ML; Crispin M; Drayson MT; Cunningham AF; Richter AG; O'Shea MK
    Emerg Infect Dis; 2020 Dec; 26(12):2970-2973. PubMed ID: 32969788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system.
    Castelletti N; Paunovic I; Rubio-Acero R; Beyerl J; Plank M; Reinkemeyer C; Kroidl I; Noreña I; Winter S; Olbrich L; Janke C; Hoelscher M; Wieser A;
    Microbiol Spectr; 2024 Apr; 12(4):e0288523. PubMed ID: 38426747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay.
    Mulchandani R; Brown B; Brooks T; Semper A; Machin N; Linley E; Borrow R; Wyllie D;
    J Clin Virol; 2021 Mar; 136():104739. PubMed ID: 33588354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples.
    Sancilio AE; D'Aquila RT; McNally EM; Velez MP; Ison MG; Demonbreun AR; McDade TW
    Sci Rep; 2021 Jul; 11(1):15321. PubMed ID: 34321523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing.
    Sims MD; Podolsky RH; Childers KL; Higgins B; Trueman J; Homayouni R; Voss DR; Berkiw-Scenna N; Keil H; Kennedy RH; Maine GN
    J Immunol Methods; 2023 Feb; 513():113420. PubMed ID: 36596443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity.
    Styer LM; Hoen R; Rock J; Yauney E; Nemeth K; Bievenue R; Parker MM
    Microbiol Spectr; 2021 Sep; 9(1):e0013421. PubMed ID: 34319133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of SARS-CoV-2 IgG antibodies in dried blood spots.
    Turgeon CT; Sanders KA; Granger D; Nett SL; Hilgart H; Matern D; Theel ES
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115425. PubMed ID: 34116343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma.
    Itell HL; Weight H; Fish CS; Logue JK; Franko N; Wolf CR; McCulloch DJ; Galloway J; Matsen FA; Chu HY; Overbaugh J
    Microbiol Spectr; 2021 Oct; 9(2):e0129821. PubMed ID: 34668728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs.
    Weisser H; Steinhagen K; Höcker R; Borchardt-Lohölter V; Anvari Ö; Kern PM
    Clin Chem Lab Med; 2021 Apr; 59(5):979-985. PubMed ID: 33554537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults.
    Ferentinos P; Snape D; Koivula F; Faustini S; Nicholson-Little A; Stacey M; Gifford R; Parsons I; Lamb L; Greeves J; O'Hara J; Cunningham AF; Woods D; Richter A; O'Shea MK
    J Immunol Methods; 2023 Jul; 518():113492. PubMed ID: 37201783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay.
    Beyerl J; Rubio-Acero R; Castelletti N; Paunovic I; Kroidl I; Khan ZN; Bakuli A; Tautz A; Oft J; Hoelscher M; Wieser A;
    EBioMedicine; 2021 Aug; 70():103502. PubMed ID: 34333234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
    Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
    Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots.
    Turgeon CT; Sanders KA; Rinaldo P; Granger D; Hilgart H; Matern D; Theel ES
    PLoS One; 2021; 16(5):e0252621. PubMed ID: 34048503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays.
    Zava TT; Zava DT
    Bioanalysis; 2021 Jan; 13(1):13-28. PubMed ID: 33319585
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2.
    Iankov I; Viker K; Turgeon C; Matern D; Galanis E
    J Immunol Methods; 2021 May; 492():112996. PubMed ID: 33582147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.